CC(C)CCNC(=O)C1CCC(Cn2c(=O)c3sccc3n(CC(=O)NC(C)C)c2=O)CC1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?